Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Alzheimers Dement. 2022 Jan 3;18(11):2067–2078. doi: 10.1002/alz.12540

Table 2.

SNP-by-AD status interaction meta-analysis for ε4-associated group-specific SNPs in the pooled samples of AD and NAD groups.

SNPs SNP-by-AD Status Interaction Effect
Rep/Meta CHR Locus Gene SNP POS EA EAF N BETA SE P-value Effects
NAD-Meta 1p31.2 1 LRRC7 rs1414663 69168451 G 0.102 11576 −0.423 0.108 8.60E-05 −−?−−
AD-Meta 8q24.22 2 KCNQ3 rs9297847 132351982 T 0.318 15047 −0.292 0.066 8.90E-06 −−−−−
AD-Meta 8q24.22 2 KCNQ3 rs4458854 132360860 A 0.338 15048 −0.277 0.065 2.00E-05 −−−−−
AD-Meta 8q24.22 2 KCNQ3 rs7820317 132362575 A 0.339 15044 −0.265 0.065 4.58E-05 −−−−−
AD-Meta 8q24.22 2 KCNQ3 rs2673604 132399360 C 0.299 15044 −0.281 0.067 2.98E-05 −−−−−
AD-Rep/NAD-Rep 19q13.32 3 NECTIN2 rs283815 44887076 G 0.307 11576 −0.274 0.052 1.54E-07 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs71352238 44891079 C 0.245 11573 −0.475 0.061 4.90E-15 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs157580 44892009 G 0.314 10506 −0.316 0.071 9.68E-06 ?−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs2075650 44892362 G 0.243 11570 −0.553 0.061 1.17E-19 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs34095326 44892587 A 0.184 11576 −0.542 0.077 1.81E-12 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs157582 44892962 T 0.307 11574 −0.282 0.052 6.53E-08 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs76366838 44896639 A 0.048 8875 −0.937 0.178 1.40E-07 −−??−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs8106922 44898409 G 0.369 11559 −0.395 0.062 2.38E-10 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs115881343 44899959 T 0.050 8874 −0.910 0.172 1.29E-07 −−??−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs1160985 44900155 T 0.391 11576 −0.435 0.061 8.42E-13 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 TOMM40 rs7259620 44904531 A 0.388 11576 −0.413 0.061 1.18E-11 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOE rs405509 44905579 G 0.437 11572 −0.286 0.063 5.06E-06 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOE rs769449 44906745 A 0.225 11573 −1.065 0.053 3.18E-91 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOE rs769450 44907187 A 0.372 11574 −0.422 0.062 1.18E-11 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOE rs75627662 44910319 T 0.228 11576 −0.994 0.053 1.40E-79 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOE rs72654473 44911142 A 0.051 11572 −0.770 0.147 1.84E-07 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOE rs439401 44911194 T 0.342 11558 −0.270 0.065 3.68E-05 +−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOC1 rs445925 44912383 A 0.054 11575 −0.741 0.144 2.71E-07 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOC1 rs483082 44912921 T 0.286 11574 −0.747 0.044 3.31E-65 −−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOC1 rs584007 44913221 A 0.341 11573 −0.274 0.065 2.81E-05 +−?−−
AD-Rep/NAD-Rep 19q13.32 3 APOC1 rs56131196 44919589 A 0.287 12347 −0.447 0.046 1.63E-22 −−−?−
AD-Rep/NAD-Rep 19q13.32 3 APOC1 rs4420638 44919689 G 0.287 12332 −0.451 0.046 8.56E-23 −−−?−
AD-Rep/NAD-Rep 19q13.32 3 APOC1 rs78959900 44920379 A 0.298 5508 −0.463 0.090 2.94E-07 −???−
AD-Rep/NAD-Rep 19q13.32 3 APOC1P1 rs4803770 44924096 G 0.325 5508 −0.516 0.087 3.36E-09 −???−
AD-Meta/NAD-Meta 19q13.32 3 APOC1P1 rs71352239 44926286 T 0.280 4450 −0.434 0.107 5.33E-05 ????−
AD-Rep 19q13.32 3 EXOC3L2 rs11083767 45212422 C 0.338 5508 −0.418 0.097 1.61E-05 −???−

Please see the description provided below Table 1.